No profile photo available

Peter J. DeMaria, MD

Languages spoken: Spanish, English

Academic Information

Departments Primary - Internal Medicine

Divisions: Oncology

Academic Office Information

peter.demaria@hci.utah.edu

Board Certification

  • American Board of Internal Medicine (Sub: Hematology)
  • American Board of Internal Medicine (Sub: Medical Oncology)
  • American Board of Internal Medicine (Internal Medicine)
  • American Board of Internal Medicine (Sub: Hospice and Palliative Medicine)

Education History

Undergraduate Dartmouth College
 BA
Professional Medical University of Miami Leonard M. Miller School of Medicine
 MD
Residency University of Miami Leonard M. Miller School of Medicine / Jackson Memorial Hospital
 Resident
Fellowship University of Miami Leonard M. Miller School of Medicine / Jackson Memorial Hospital
 Fellow
Fellowship National Cancer Institute / National Institutes of Health
 Fellow
Fellowship U.S. Food and Drug Administration
 Fellow

Selected Publications

Journal Article

  1. Nathenson MJ, Hu J, Ratan R, Somaiah N, Hsu R, DeMaria PJ, Catoe HW, Pang A, Subhawong TK, Amini B, Sweet K, Feister K, Malik K, Jagannathan J, Braschi-Amirfarzan M, Sheren J, Caldas Y, Moreno Tellez C, Rosenberg AE, Lazar AJ, Maki RG, Benedetto P, Cohen J, Trent JC, Ravi V, Patel S, Wilky BA (2022). Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study. Clin Cancer Res, 28(18), 4092-4104.
  2. DeMaria PJ, Lee-Wisdom K, Donahue RN, Madan RA, Karzai F, Schwab A, Palena C, Jochems C, Floudas C, Strauss J, Mart� JL, Redman JM, Dombi E, Widemann B, Korchin B, Adams T, Pico-Navarro C, Heery C, Schlom J, Gulley JL, Bilusic M (2021). Phase 1 open-label trial of intravenous administration of MVA-BN-brachyury-TRICOM vaccine in patients with advanced cancer. J Immunother Cancer, 9(9).
  3. DeMaria PJ, Bilusic M, Park DM, Heery CR, Donahue RN, Madan RA, Bagheri MH, Strauss J, Shen V, Marté JL, Steinberg SM, Schlom J, Gilbert MR, Gulley J (2021). Randomized, Double-Blind, Placebo-Controlled Phase II Study of Yeast-Brachyury Vaccine (GI-6301) in Combination with Standard-of-Care Radiotherapy in Locally Advanced, Unresectable Chordoma. The oncologist, 26(5), e847-e858.

Review

  1. Jani CT, Manoharan A, DeMaria PJ, Bilusic (2025). Harnessing live vectors for cancer vaccines: Advancing therapeutic immunotherapy. Human vaccines & immunotherapeutics, 21(1), 2469416.
  2. Cortes JE, Abruzzese E, Cardonick EH, Hernández-Díaz S, Gutierrez J, Sardegna MS, Torres-Chavez E, Dinatale M, Lerro CC, Gehrke BJ, Shord SS, De Claro RA, Theoret MR, DeMaria PJ, Norsworthy K (2024). Perspectives on Drug Development for the Treatment of Chronic Myeloid Leukemia in Pregnant Patients and Patients Who Are Breastfeeding. Clinical cancer research, 30(17), 3658-3666.
  3. Leong R, Grimstein M, DeMaria P, Norsworthy KJ, Fletcher EP, Shord (2023). Landscape and Regulatory Perspective on Oncology Drugs in Pregnancy. Journal of clinical pharmacology, 63 Suppl 1, S170-S175.
  4. DeMaria PJ, Bilusic (2019). Cancer Vaccines. Hematology/oncology clinics of North America, 33(2), 199-214.
  5. Glassner S, Srivastava K, Cofnas P, Deegan B, Demaria P, Denis R, Ginzburg (2013). Prevention of venous thrombotic events in brain injury: review of current practices. Rambam Maimonides medical journal, 4(1), e0001.